Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06735014 · ClinicalTrials.gov registry record

Multicenter ALS Imaging Study

A clinical trial of Amyotrophic Lateral Sclerosis and ALS, sponsored by University of Minnesota.

Recruiting
Registry status
90
Enrollment target
3
Study locations

NCT06735014 is a study of Amyotrophic Lateral Sclerosis and ALS that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 90 participants, below the 897-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06735014, a study of Amyotrophic Lateral Sclerosis and ALS, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
90 participants
Enrollment target
3
Study locations

Study Summary

This is a multi-site study of ALS participants and healthy controls who will undergo brain and cervical spine MRIs and NfL blood testing at up-to 4 time points over the course of a year. The primary goal is to identify objective biomarkers of disease progression that are biologically relevant, linearly progressive, and sensitive to change.

Conditions Studied

Amyotrophic Lateral Sclerosis ALS

Interventions

  • DIAGNOSTIC_TEST Magnetic Resonance Imaging
  • DIAGNOSTIC_TEST Plasma neurofilament light chain (NfL) quantification

Study Locations (3)

Florida

  • University of Florida - Gainesville

Illinois

  • Northwestern University - Evanston

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-09-15
Est. Completion 2028-08-31

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06735014

The ClinicalTrials.gov registry entry for NCT06735014 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 897-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (90% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.

NCT06735014 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06735014 about?

NCT06735014 is a clinical study titled "Multicenter ALS Imaging Study". This is a multi-site study of ALS participants and healthy controls who will undergo brain and cervical spine MRIs and NfL blood testing at up-to 4 time points over the course of a year. The primary goal is to identify objective biomarkers of disease progression that are biologically relevant, linea...

What is the current status of trial NCT06735014?

This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2024-09-15. Estimated completion is 2028-08-31.

What conditions does trial NCT06735014 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, ALS.

What interventions are being tested in trial NCT06735014?

The interventions under investigation include: Magnetic Resonance Imaging (DIAGNOSTIC_TEST), Plasma neurofilament light chain (NfL) quantification (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06735014?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06735014 being conducted?

This trial has 3 study locations across Florida, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyotrophic Lateral Sclerosis

All registered trials for this condition

ALS

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.